579 Phase I and Pharmacokinetic (PK) Study of Pazopanib in Combination with Two Schedules of Docetaxel (D) in Patients (pts) with Advanced Solid Tumors

✍ Scribed by Hamberg, P.; Mathijssen, R.H.; de Bruijn, P.; van der Biessen, D.; Loos, W.J.; Sleijfer, S.; Verweij, J.; de Jonge, M.J.

• Book ID: 122459432
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 56 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(12)72376-6